Stocks  /  NASDAQ  /  Kardigan Inc.

Kardigan Inc.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   KARD – NASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Kardigan Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for drug testing.

“In the setting of myosin-inhibition mimicking MYH7 DCM mutations, Danicamtiv was observed to restore function both biochemically and biomechanically, restoring enzymatic activity of myofibrils and restoring systolic tension in skinned isolated fibers, resulting in the restoration of cardiac function and cardiac output production in vivo in both rats and pigs.” (Page 158) Read the full document

Company Description

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. The company was formerly known as EnCarda, Inc. and changed its name to Kardigan, Inc. in December 2024. The company was founded in 2023 and is based in Princeton, New Jersey.

Company Website: https://www.kardigan.bio

Contact:  investors@kardigan.bio
Scroll to Top